B.F. Leeb
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Osteoarthritis Treatment and Mechanisms
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Rheumatoid Arthritis Research and Therapies 3
- Systemic Lupus Erythematosus Research 2
- Spondyloarthritis Studies and Treatments 1
-
- Forensic Toxicology and Drug Analysis 1
- Co-authors
- J S Smolen (2 shared papers)Attila Dunky (2 shared papers)Gerald Partsch (3 shared papers)Guenter Steiner (1 shared paper)H Bröll (2 shared papers)Gérard Eberl (2 shared papers)Klaus Peter Machold (1 shared paper)J. D. Irving (1 shared paper)
In The Last Decade
B.F. Leeb
9 papers receiving 326 citations
Peers
Comparison fields: 5 of 49
- Rheumatology 236
- Hematology 86
- Toxicology 21
- Immunology 114
- Pharmacology 25
Countries citing papers authored by B.F. Leeb
This map shows the geographic impact of B.F. Leeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.F. Leeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.F. Leeb more than expected).
Fields of papers citing papers by B.F. Leeb
This network shows the impact of papers produced by B.F. Leeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.F. Leeb. The network helps show where B.F. Leeb may publish in the future.
Co-authors
The 24 scholars most cited alongside B.F. Leeb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid. | 1997 | 261 |
| 2 | 1984 | 32 | |
| 3 | Early arthritis therapy: rationale and current approach. | 1998 | 31 |
| 4 | [Results of a multicenter study of chondroitin sulfate (Condrosulf) use in arthroses of the finger, knee and hip joints]. | 1996 | 12 |
| 5 | 2013 | 9 | |
| 6 | Methotrexate serum-level determinations during low-dose therapy of rheumatoid and psoriatic arthritis. | 1989 | 7 |
| 7 | 2020 | 6 | |
| 8 | Low serum hyaluronan in psoriatic arthritis patients in comparison to rheumatoid arthritis patients. | 1997 | 5 |
| 9 | 1994 | 5 |
About B.F. Leeb
B.F. Leeb is a scholar working on Rheumatology, Toxicology, Oncology, Hematology and Pharmacology, having authored 9 papers that have together received 368 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (3 papers), Systemic Lupus Erythematosus Research (2 papers), Cannabis and Cannabinoid Research (1 paper), Autoimmune and Inflammatory Disorders Research (1 paper), Forensic Toxicology and Drug Analysis (1 paper), Spondyloarthritis Studies and Treatments (1 paper), Atrial Fibrillation Management and Outcomes (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Rheumatology (236 citations), Hematology (86 citations), Toxicology (21 citations), Immunology (114 citations) and Pharmacology (25 citations). B.F. Leeb has collaborated with scholars based in Austria, Japan and Italy. Frequent co-authors include J S Smolen, Attila Dunky, Gerald Partsch, Guenter Steiner, H Bröll, Gérard Eberl, Klaus Peter Machold, J. D. Irving, Valerie P. K. Nell and C. E. Cook. Their work appears in journals such as Lara D. Veeken, Journal of Analytical Toxicology, Annals of the Rheumatic Diseases and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.